Skip to main content
Membership NewsMembership News Archive

Beth Loudon to join BIVDA

BIVDA continues to strengthen our team, and we are delighted to welcoming Beth Loudon as our new Head of Market Access from September 2024. Beth is currently the Medical and Surgical Consumables Director for NHS Supply Chain, leading the clinical and commercial team responsible for assurance of value and resilience for the supply of clinical goods to the NHS. Beth brings…
Ben Kemp
June 17, 2024
Membership NewsMembership News Archive

BIVDA responds to the Labour Party’s manifesto

Last week saw the launch of the Labour Party’s manifesto ahead of the general election in two weeks’ time. While there were no great surprises in their document, we welcome the pledge to shift resources to primary and community care, including trialling Neighbourhood Health Centres, which should yield earlier diagnoses and improve patient outcomes. The commitment to developing NHS innovation…
Ben Kemp
June 17, 2024
Membership NewsMembership News Archive

Remembering Dr Michael Mosley: 1957 -2024

BIVDA are saddened to hear of the death of Dr Michael Mosley. Dr Mosley was the compere and after-dinner speaker at our 30th anniversary event, where he was witty, human, and insightful. With his balance of knowledge, education, and communication he did much to advance the cause of science and lead important conversations about the importance of health. All at…
Ben Kemp
June 12, 2024
Membership NewsMembership News Archive

MHRA launches public consultation on common specifications for high-risk IVDs

The MHRA have launched a 4-week public consultation on common specification requirements for high risk IVDs. They are seeking views on the inclusion of these requirements for certain high-risk IVDs and on the removal of the Coronavirus Test Device Approval (CTDA) process from UK MDR 2002. This would avoid duplication of regulatory requirements for COVID-19 test devices. The common specification…
Ben Kemp
June 12, 2024
Membership NewsMembership News Archive

BIVDA responds to integrated, rules-based medtech pathway consultation

NHS England and NICE have launched a consultation on a proposed integrated, rules-based pathway for the evaluation, funding, and commissioning of medical technologies. It's been recognised after years of system-wide feedback that the current process is challenging for our established members and even more so for new entrants. It also demonstrates their understanding around a marked difference in approach between…
Ben Kemp
June 12, 2024
Membership NewsMembership News Archive

Examining the health and life science pledges in the Conservative and Lib Dem Manifestos

On Monday, the Lib Dems were the first of the three major parties to release their manifesto. Owing to Ed Davey's personal connection, the document focused heavily on social care. BIVDA is pleased to see the Lib Dems' pledge to review diagnostic provision across the NHS and implement a new ten-year Strategic Diagnostics Plan. This recognises the continued importance of…
Ben Kemp
June 12, 2024
HighlightsHighlights Archive

Media Monitoring: 6 – 11 June

Major cause of Inflammatory Bowel Disease discovered A groundbreaking piece of research has been published this week that could lead to greater understanding of Crohn’s and Colitis and possibly new treatments in the future. Using genetic analysis, the researchers found a section of genetic code (DNA) that is active in macrophages. Macrophages are a type of immune cell that cause…
Ben Kemp
June 11, 2024
HighlightsHighlights Archive

New flu biomarkers discovery could lead to personalised vaccine schedules

Researchers have identified new biomarkers that could enable personalised flu vaccination schedules, ensuring longer-lasting immunity. The findings were presented at the European Society of Human Genetics meeting and involves classifying individual immune responses to predict who may not be adequately protected by standard flu vaccines. By using multiomics technology, the study analysed blood samples to identify predictive markers, aiming to…
Ben Kemp
June 11, 2024